Free Trial
NASDAQ:KLTO

Klotho Neurosciences (KLTO) Stock Price, News & Analysis

Klotho Neurosciences logo
$1.54 +0.04 (+2.67%)
As of 06/20/2025 04:00 PM Eastern

About Klotho Neurosciences Stock (NASDAQ:KLTO)

Key Stats

Today's Range
$1.41
$1.67
50-Day Range
$0.13
$2.01
52-Week Range
$0.11
$5.80
Volume
6.32 million shs
Average Volume
30.87 million shs
Market Capitalization
$50.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Receive KLTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Klotho Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

KLTO Stock News Headlines

Contrasting Klotho Neurosciences (KLTO) and Its Rivals
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Comparing Klotho Neurosciences (KLTO) & Its Peers
See More Headlines

KLTO Stock Analysis - Frequently Asked Questions

Klotho Neurosciences' stock was trading at $0.4850 at the beginning of the year. Since then, KLTO shares have increased by 217.5% and is now trading at $1.54.
View the best growth stocks for 2025 here
.

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced its earnings results on Thursday, May, 15th. The company reported ($0.08) earnings per share for the quarter.

Shares of KLTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
6/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KLTO
Previous Symbol
NASDAQ:KLTO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.15 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
38.50

Miscellaneous

Free Float
23,818,000
Market Cap
$50.03 million
Optionable
N/A
Beta
0.18
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:KLTO) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners